BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Policy

  Rare Cancers Europe Calls For New Criteria To Be Used In Clinical Trials On Rare Cancer Treatments

  October 2, 2014

   · 

  4 min read
• Drug Development

  Isis Pharmaceuticals, Inc. To Host Webcast To Discuss ISIS-SMN Rx Results Presented At The World Muscle Society Congress

  October 2, 2014

   · 

  2 min read
• Pharm Country

  Echo Therapeutics Comments On Unauthorized Public Statements By Michael M. Goldberg, M.D. And Shepard M. Goldberg

  October 2, 2014

   · 

  6 min read
• Deals

  Prima Biomed Secures $37.4 Million To Fund Immutep S.A. Acquisition

  October 2, 2014

   · 

  7 min read
• Business

  VolitionRX Announces Prostate Cancer Collaboration With The University of Texas MD Anderson Cancer Center

  October 2, 2014

   · 

  5 min read
• Business

  Mast Therapeutics Announces Appointment Of Chief Medical Officer

  October 2, 2014

   · 

  6 min read
• Drug Development

  FDA Grants Fast Track Designation To NKT Therapeutics Inc.’ NKTT120 For The Treatment Of Sickle Cell Disease

  October 2, 2014

   · 

  1 min read
• Deals

  SSF’s Calithera Biosciences, Inc. Prices IPO At $10 A Share, Below The Range

  October 2, 2014

   · 

  2 min read
• Deals

  Sagent Pharmaceuticals, Inc. Bags Omega Laboratories For $85.3 Million Cash

  October 2, 2014

   · 

  8 min read
• Business

  Cepheid Snags LABSCO Customer Relationships For $21 Million

  October 2, 2014

   · 

  4 min read